Erratum: Efficacy and safety of piascledine 300 versus chondroitin sulfate in a 6 months treatment plus 2 months observation in patients with osteoarthritis of the knee (Clinical Rheumatology DOI: 10.1007/s10067-010-1384- 8)

Karel Pavelka, Philippe Coste, Pál Géher, Gerhard Krejci

Research output: Contribution to journalComment/debate

Original languageEnglish
Number of pages1
JournalClinical rheumatology
Issue number7
Publication statusPublished - Jul 1 2010

ASJC Scopus subject areas

  • Rheumatology

Cite this